Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Intravitreal Fluocinolone Acetonide in Retinitis Pigmentosa
2016-002523-28Phase 2Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluocinolone in retinitis pigmentosa (RP) (2 arms), sponsored by Moorfields Eye Hospital. Primary endpoint: Anatomical and functional retinal changes. Started Jul 2016; status: completed.
02
Drugs
fluocinolone
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on 2016-002523-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002523-28.